Search

Displaying results 7121 - 7130 of 10000 in total
  1. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational

  2. Drug

    CRD5

    go.drugbank.com/drugs/DB05587
    Experimental

  3. Drug

    Freselestat

    go.drugbank.com/drugs/DB03925
    Experimental

  4. Drug

    Emfilermin

    go.drugbank.com/drugs/DB06562
    Investigational

  5. Drug

    Fibroblast growth factor-1

    go.drugbank.com/drugs/DB05599
    Investigational

  6. Drug

    CTCE-9908

    go.drugbank.com/drugs/DB05625
    Investigational

    Synonyms: L-Lysinamide,N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-
  7. Drug

    Pemoline

    go.drugbank.com/drugs/DB01230
    ApprovedIllicitWithdrawn

    In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.

  8. Drug

    Methapyrilene

    go.drugbank.com/drugs/DB04819
    ApprovedWithdrawn

    Methapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.

    Synonyms: N,N-dimethyl-N'-pyrid-2-yl-N'-2-thenylethylenediamine, N,N-dimethyl-N'-pyridin-2-yl-N'-(2-thienylmethyl)ethane-1,2-diamine
  9. Drug

    MORF-057

    go.drugbank.com/drugs/DB23674
    Investigational

    MORF-057 is a small molecule drug. MORF-057 is under investigation in clinical trial NCT06226883 (A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease).

  10. Drug

    SHR-1179

    go.drugbank.com/drugs/DB33981
    Experimental

    SHR-1179 is a small molecule drug. … SHR-1179 is under investigation in clinical trial NCT07826364 (A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity).